Es gab 50 kürzliche Insider-Transaktionen für Jasper Therapeutics, Inc. (JSPR), darunter 48 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $19.98M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mahal Jeetinder Singh, Martell Ron, Cross Herb. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — JSPR
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-06 |
Mahal Jeetinder Singh |
CEO and President |
RSU-Zuteilung |
500,000 |
$1.35 |
$675K |
500,000 |
| 2026-01-02 |
Martell Ron |
President, CEO and Director |
RSU-Zuteilung |
234,000 |
$1.84 |
$430.56K |
234,000 |
| 2026-01-02 |
Cross Herb |
Chief Financial Officer |
RSU-Zuteilung |
90,000 |
$1.84 |
$165.6K |
90,000 |
| 2026-01-02 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU-Zuteilung |
90,000 |
$1.84 |
$165.6K |
90,000 |
| 2025-09-22 |
Martell Ron |
President and CEO |
Informierter Kauf |
41,000 |
$2.92 |
$119.72K |
41,000 |
| 2025-09-22 |
Wiggans Thomas G |
Director |
Informierter Kauf |
41,000 |
$2.92 |
$119.72K |
41,000 |
| 2025-09-22 |
Lucas Svetlana |
Director |
Informierter Kauf |
20,000 |
$2.92 |
$58.4K |
20,000 |
| 2025-09-22 |
Shizuru Judith Anne |
Director |
Informierter Kauf |
41,000 |
$2.92 |
$119.72K |
41,000 |
| 2025-07-03 |
Wiggans Thomas G |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Emster Kurt Von |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Lucas Svetlana |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Nolet Chris |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Kapoor Vishal |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Brun Scott C. |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-07-03 |
Shizuru Judith Anne |
Director |
RSU-Zuteilung |
7,500 |
$6.77 |
$50.78K |
7,500 |
| 2025-06-04 |
Martell Ron |
President and CEO |
RSU-Zuteilung |
234,000 |
$6.00 |
$1.4M |
234,000 |
| 2025-06-04 |
Cross Herb |
Chief Financial Officer |
RSU-Zuteilung |
90,000 |
$6.00 |
$540K |
90,000 |
| 2025-06-04 |
Tucker Edwin Jonathan |
Chief Medical Officer |
RSU-Zuteilung |
90,000 |
$6.00 |
$540K |
90,000 |
| 2025-06-04 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU-Zuteilung |
90,000 |
$6.00 |
$540K |
90,000 |
| 2025-02-13 |
Martell Ron |
President, CEO and Director |
RSU-Zuteilung |
130,000 |
$6.20 |
$806K |
130,000 |
| 2025-02-13 |
Cross Herb |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$6.20 |
$310K |
50,000 |
| 2025-02-13 |
Tucker Edwin Jonathan |
Chief Medical Officer |
RSU-Zuteilung |
50,000 |
$6.20 |
$310K |
50,000 |
| 2025-02-13 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU-Zuteilung |
50,000 |
$6.20 |
$310K |
50,000 |
| 2024-12-12 |
Mahal Jeetinder Singh |
Chief Operating Officer |
Optionsausübung |
900 |
$7.10 |
$6.39K |
13,772 |
| 2024-09-12 |
Mahal Jeetinder Singh |
Chief Operating Officer |
Optionsausübung |
900 |
$7.10 |
$6.39K |
14,672 |
| 2024-06-18 |
Lucas Svetlana |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-06-18 |
Lucas Svetlana |
Director |
RSU-Zuteilung |
15,000 |
$23.19 |
$347.85K |
15,000 |
| 2024-06-12 |
Mahal Jeetinder Singh |
Chief Operating Officer |
Optionsausübung |
900 |
$7.10 |
$6.39K |
15,572 |
| 2024-06-10 |
Martell Ron |
President, CEO and Director |
RSU-Zuteilung |
10,000 |
$23.95 |
$239.5K |
10,000 |
| 2024-06-07 |
Tucker Edwin Jonathan |
Chief Medical Officer |
RSU-Zuteilung |
400 |
$4.17 |
$1.67K |
400 |
| 2024-06-06 |
Wiggans Thomas G |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
Emster Kurt Von |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
Nolet Chris |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
Kapoor Vishal |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
Brun Scott C. |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
French Anna Louise |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-06-06 |
Shizuru Judith Anne |
Director |
RSU-Zuteilung |
7,500 |
$25.41 |
$190.58K |
7,500 |
| 2024-03-12 |
Mahal Jeetinder Singh |
Chief Operating Officer |
Optionsausübung |
900 |
$7.10 |
$6.39K |
16,472 |
| 2024-02-15 |
Martell Ron |
President, CEO and Director |
RSU-Zuteilung |
100,000 |
$17.95 |
$1.8M |
100,000 |
| 2024-02-15 |
Cross Herb |
Chief Financial Officer |
RSU-Zuteilung |
40,000 |
$17.95 |
$718K |
40,000 |
| 2024-02-15 |
Tucker Edwin Jonathan |
Chief Medical Officer |
RSU-Zuteilung |
45,000 |
$17.95 |
$807.75K |
45,000 |
| 2024-02-15 |
Mahal Jeetinder Singh |
Chief Operating Officer |
RSU-Zuteilung |
40,000 |
$17.95 |
$718K |
40,000 |
| 2024-02-08 |
Velan Capital Investment Management Lp |
10 Percent Owner |
Informierter Kauf |
350,000 |
$12.95 |
$4.53M |
1,188,500 |
| 2024-02-08 |
Carlyle Group Inc. |
Other: Former 10% Owner |
Informierter Kauf |
190,000 |
$12.95 |
$2.46M |
1,066,189 |
| 2023-11-28 |
Wiggans Thomas G |
Director |
Informierter Kauf |
10,000 |
$0.65 |
$6.49K |
50,000 |
| 2023-11-21 |
Wiggans Thomas G |
Director |
Informierter Kauf |
10,000 |
$0.64 |
$6.38K |
40,000 |
| 2023-11-20 |
Wiggans Thomas G |
Director |
Informierter Kauf |
10,000 |
$0.63 |
$6.31K |
30,000 |
| 2023-11-17 |
Wiggans Thomas G |
Director |
Informierter Kauf |
10,000 |
$0.60 |
$5.97K |
20,000 |
| 2023-11-16 |
Wiggans Thomas G |
Director |
Informierter Kauf |
10,000 |
$0.60 |
$5.97K |
10,000 |
| 2023-11-01 |
Wiggans Thomas G |
Director |
Unbekannt |
- |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
